Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

gadofosveset trisodium

The trisodium salt form of gadofosveset, an injectable, intravascular, amphiphilic gadolinium-based contrast agent (GBCA) used with magnetic… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (4)

Contrast MediaGadoliniumOrganometallic Compoundsgadofosveset

Narrower (2)

MS 325Vasovist
gadofosveset trisodium 244 MILLIGRAM In 1 MILLILITER INTRAVENOUS INJECTION [Vasovist]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Gadofosveset trisodium: abdominal and peripheral vascular applications.
OBJECTIVE The purpose of this review is to illustrate various applications of gadofosveset trisodium in evaluating abdominal and… 
2012
2012
Magnetic resonance VIBE venography using the blood pool contrast agent gadofosveset trisodium--an interrater reliability study.
PURPOSE In this study, image quality of leg veins and vena cava inferior was scored by independent raters using the new… 
2012
2012
Towards Endometriosis Diagnosis by Gadofosveset-Trisodium Enhanced Magnetic Resonance Imaging
Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10–15% of women during reproductive… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
OBJECTIVE This prospective multicenter intraindividual crossover study was designed to compare gadobenate dimeglumine and… 
  • table 1
  • figure 1—62
  • table 4
  • figure 2—73
2009
2009
First‐pass and steady‐state magnetic resonance angiography of the thoracic vasculature using gadofosveset trisodium
To compare a high‐resolution, ECG‐gated, motion‐compensated, steady‐state magnetic resonance angiography (SS‐MRA) of the thoracic… 
Highly Cited
2007
Highly Cited
2007
First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset Trisodium: Comparison to Gadopentetate Dimeglumine
Objectives:To evaluate gadofosveset trisodium for first-pass magnetic resonance angiography (MRA) in the setting of whole-body… 
2006
2006
Preclinical Safety Assessment of Vasovist (Gadofosveset trisodium), a New Magnetic Resonance Imaging Contrast Agent for Angiography
Objectives:Vasovist (EPIX Pharmaceuticals and Schering AG) is a newly developed blood pool contrast agent for magnetic resonance… 
Review
2006
Review
2006
High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience.
The purpose of this study was to prospectively evaluate the diagnostic accuracy of reader detection of 75% or greater stenosis at… 
Review
2005
Review
2005
MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325.
PURPOSE To evaluate prospectively the safety and effectiveness of aortoiliac magnetic resonance (MR) angiography enhanced with MS… 
Highly Cited
2003
Highly Cited
2003
MR angiography with gadofosveset trisodium for peripheral vascular disease: phase II trial.
PURPOSE To evaluate the dose response and safety of gadofosveset trisodium-enhanced magnetic resonance (MR) angiography compared… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE